Antiarrhythmic Potential of Epicardial Botulinum Toxin Injection for
Suppression of Postoperative Atrial Fibrillation
Michael Spartalis,
Eleftherios Spartalis,
Dimitrios Iliopoulos
et al.
Abstract:Following heart surgery, postoperative atrial fibrillation (AF) is the most prevalent kind of secondary AF and the most frequent adverse event.
Postoperative AF is related to a number of unfavorable cardiac outcomes, such as heart failure, stroke, and death. However, the pharmacological
treatment for postoperative AF is only relatively efficient and is frequently linked to detrimental complications, including symptomatic bradycardia
with atrioventricular block due to rate control drugs and elevated hemorrhage … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.